Articles by James Calloway
Ford Boosts 2026 Outlook with $1.3B Tariff Refund, F-150 Woes Linger
Ford raised its 2026 adjusted EBIT outlook to $8.5-$10.5 billion after a $1.3 billion tariff refund, though F-150 production fell 12% and aluminum costs remain a concern.
Quanta Services Soars on Record Backlog and Raised Guidance
Quanta Services shares jumped $71.30 to $699.90 after Q1 earnings beat and raised 2026 guidance, powered by a record $48.5 billion backlog.
Altria Shares Surge 7% on Q1 Earnings Beat Amid Price Hikes
Altria shares rose 7% after Q1 earnings beat estimates, driven by price hikes that offset a 2.4% drop in cigarette shipments.
Mastercard Beats Q1 Estimates but April Cross-Border Weakness Weighs on Stock
Mastercard beat Q1 earnings and revenue estimates, but a slowdown in April cross-border volume growth triggered a 2.7% stock decline.
Viavi Solutions Soars 20% on Strong Earnings, AI Data Center Demand
Viavi Solutions shares jumped about 20% after fiscal Q3 revenue rose 42.8% to $406.8 million, beating estimates, driven by AI data center and aerospace demand.
Plug Power Shares Dip 7% as Investor Focus Shifts to Q1 Cash Burn
Plug Power shares slid 7% Thursday, paring Wednesday's rally as investors await Q1 results on May 11. Focus is on cash burn and path to positive EBITDA.
Lemonade Shares Dip Despite Strong Q1 Revenue Growth and Narrowed Loss
Lemonade posted a 71% revenue jump and a narrower loss in Q1, yet shares slipped 1.3%. The company raised its 2026 outlook and reiterated its Q4 adjusted EBITDA target.
Zoom to Report Q1 FY2027 Earnings on May 21, AI and Margins in Focus
Zoom will report Q1 FY2027 earnings on May 21. The stock gained 5.07% after Vanguard disclosed a 5.05% passive stake. Revenue rose 5.3% last quarter.
Qualcomm Surges on AI Data-Center Push Despite Weak Q3 Forecast
Qualcomm shares rose 10.3% premarket Thursday after CEO Cristiano Amon said the smartphone market has bottomed and highlighted AI data-center chip progress, offsetting a weak Q3 forecast.
Eli Lilly Lifts 2026 Guidance After GLP-1 Sales Surge 56% in Q1
Eli Lilly boosted its 2026 revenue outlook by $2 billion after Q1 sales jumped 56% to $19.8 billion, propelled by Mounjaro and Zepbound. The company also launched oral GLP-1 pill Foundayo.
Caterpillar Profit Surges on AI Data Center Demand, Tariff Costs Loom
Caterpillar Q1 adjusted EPS of $5.54 beat estimates on 41% power-generation growth from AI data centers. Shares rose 5% premarket; tariff costs seen at $2.2-$2.4B.